与心力衰竭相关的并发症中的分子重塑:当前更新
Sandeep Appunni1, Muni Rubens2,3,4, Venkataraghavan Ramamoorthy5
1Government Medical College, Kozhikode, Kerala, India.
Molecular biology reports
|October 26, 2024
概括
这篇评论详细介绍了心力衰竭并发症 (如肥胖和糖尿病) 的分子变化. 了解这些途径可以为心力衰竭患者提供新的,个性化的治疗方法.
科学领域:
- 心血管医学 心血管医学
- 分子生物学分子生物学
- 基因组学和蛋白质组学
背景情况:
- 心力衰竭经常与肥胖,糖尿病,高血压和冠状动脉疾病等并发症同时发生.
- 已确定的并发症和心力衰竭之间的关联现在正在在更深层次的分子层面上进行探索.
- 基因组学和蛋白质组学的进步为心力衰竭及其常见并发症之间的复杂相互作用提供了新的见解.
研究的目的:
- 审查与心力衰竭相关的常见并发症中的分子变化.
- 阐明如何理解这些分子通路可以为开发新型心力衰竭疗法提供信息.
- 突出个性化医疗策略在治疗伴随疾病的心力衰竭方面的潜力.
主要方法:
- 电子数据库的叙述性审查,包括PubMed,奥维德,EMBASE,谷歌学者,CINAHL和PhysioNet.
- 在没有时间限制的情况下搜索文章,以捕捉最近的进展.
- 专注于将并发症与心力衰竭联系起来的分子机制和途径.
主要成果:
- 详细审查了肥胖,糖尿病,全身高血压,肺高血压,冠状动脉疾病,高胆固醇,慢性脏疾病和心房动的细节分子变化.
- 最近的研究提供了对分子途径的深入探索,揭示了新型心力衰竭药物如何与伴随性疾病相关途径相互作用.
- 心力衰竭和并发性疾病中变化的分子环境为新药开发提供了目标.
结论:
- 了解心力衰竭并发症的分子基础对于开发向和新型药物至关重要.
- 结合个体分子变异的个性化治疗方法可以改善治疗结果.
- 这种知识对于在心血管保健中推进精准医学策略至关重要.
相关概念视频
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:29Heart Failure II: Pathophysiology
1
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
394
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
394
01:27Heart Failure I: Introduction
1
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1
01:30Heart Failure V: Medical Management
1
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
1
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...